In preclinical literature, Chonluten (Glu-Asp-Gly) demonstrates marked anti-inflammatory properties by modulating pro-inflammatory cytokine secretion, restoring bronchial epithelial barrier integrity, and regulating gene expression. When evaluating the antiinflammatory properties Chonluten price for laboratory procurement, costs depend primarily on peptide purity (>98% verified by RP-HPLC/MS), endotoxin screening, lot-specific COAs, and domestic synthesis quality.
In preclinical literature, Chonluten (Glu-Asp-Gly) demonstrates marked anti-inflammatory properties by modulating pro-inflammatory cytokine secretion, restoring bronchial epithelial barrier integrity, and regulating gene expression. When evaluating the antiinflammatory properties Chonluten price for laboratory procurement, costs depend primarily on peptide purity (>98% verified by RP-HPLC/MS), endotoxin screening, lot-specific COAs, and domestic synthesis quality.
Chonluten is a synthetic short tripeptide composed of L-glutamic acid, L-aspartic acid, and glycine (Glu-Asp-Gly). Developed within the framework of peptide bioregulation research, Chonluten belongs to a class of short-chain amino acid sequences designed to target specific cellular pathways in bronchial and respiratory tissues. Short peptides of this nature interact directly with chromatin structures, nucleosomes, and cell surface receptors to alter cellular homeostasis.
In laboratory settings, Chonluten is studied exclusively as a research compound to elucidate fundamental mechanisms of epithelial preservation, cellular senescence retardance, and local immune response modulation. When purchasing this sequence for standard in vitro assays or preclinical animal models, researchers must evaluate both structural fidelity and chemical purity to ensure experimental reproducibility across trials.
Investigations examining the anti-inflammatory profile of Chonluten focus heavily on its ability to downregulate pro-inflammatory signaling cascades. In vitro assays utilizing bronchial epithelial cell lines exposed to endotoxins or oxidative stressors show that Chonluten administration attenuates the overexpression of nuclear factor kappa B (NF-κB). This key transcription factor drives the expression of inflammatory mediators.
Preclinical rodent models of acute lung injury indicate that treatment with Glu-Asp-Gly reduces the local concentrations of major pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6). Concurrently, preclinical data demonstrate an upregulation of anti-inflammatory markers and protective enzymes, helping preserve tissue architecture during induced respiratory inflammation. Researchers can explore detailed biochemical profiles in our research library hub.
Beyond direct cytokine inhibition, short tripeptides like Chonluten participate in epigenetic regulation. In vitro molecular binding assays reveal that Glu-Asp-Gly can penetrate nuclear membranes and interact with double-stranded DNA at specific promoter regions. This interaction alters histone acetylation states, thereby modulating the transcription rate of genes involved in surfactant production and cellular repair.
In cell culture models of respiratory epithelium, Chonluten maintains tight junction integrity by stabilizing proteins such as zonula occludens-1 (ZO-1) and occludin. Under hypoxic or inflammatory conditions, control cultures exhibit severe junctional breakdown, whereas cultures supplemented with synthetic tripeptides display preserved trans-epithelial electrical resistance (TEER). For broader context on short sequence genomic interaction, see our analysis on tripeptide gene expression mechanisms.
When assessing the market landscape for antiinflammatory properties Chonluten price metrics, procurement officers and principal investigators must look beyond simple unit cost per milligram. The primary cost drivers for high-grade research peptides center around manufacturing rigor, verification protocols, and purity thresholds required for clean experimental execution.
Low-cost peptides frequently suffer from batch-to-batch variation, residual TFA (trifluoroacetic acid) contamination, heavy metal carryover, or incorrect sequence synthesis. High-purity peptides synthesized in GMP-compliant, US-manufactured facilities command a higher price point due to extensive post-synthesis purification via reverse-phase high-performance liquid chromatography (RP-HPLC) and continuous mass spectrometry (MS) validation. Review standard purity tiers in our catalog of research peptides.
To properly evaluate Chonluten within its structural and functional class, researchers often compare it against other short synthetic peptide bioregulators targeting immune and tissue pathways. Each peptide exhibits distinct amino acid sequences, tissue affinities, and inflammatory modulation profiles in laboratory settings.
For instance, while Chonluten (Glu-Asp-Gly) specifically targets bronchial tissue integrity and local cytokine suppression, Bronchogen (Ala-Glu-Asp-Leu) focuses on remodeling extracellular matrix components in pulmonary models. Meanwhile, Thymogen (Glu-Trp) acts primarily on systemic T-cell differentiation and systemic immune regulation, and BPC-157 offers broader cytoprotective mechanisms across gastrointestinal and musculoskeletal tissues. Selecting the appropriate sequence depends on whether the protocol requires targeted bronchial epithelia response or broad systemic cytokine control.
To ensure that observed anti-inflammatory effects stem solely from the synthetic tripeptide rather than impuritites, laboratory standards mandate rigorous analytical testing. Every lot of Chonluten synthetic peptide supplied by PX1 Research undergoes strict analytical validation in an ISO 17025 accredited laboratory.
Researchers receive a comprehensive, lot-specific Certificate of Analysis (COA) containing RP-HPLC chromatograms verifying >98% chemical purity. Electrospray ionization mass spectrometry (ESI-MS) confirms exact molecular weight and amino acid sequence identity. Furthermore, quantitative chromogenic Limulus Amebocyte Lysate (LAL) testing is performed to ensure endotoxin levels remain below stringent research limits (<0.5 EU/mg), eliminating false-positive inflammatory responses in cell culture assays.
Lyophilized Chonluten powder must be stored under controlled conditions to maintain chemical stability. Upon arrival, un-reconstituted vials should be kept at -20°C in a desiccated environment. Exposure to ambient moisture, heat, or direct sunlight can accelerate hydrolysis of the peptide bonds, altering final concentration and activity.
For laboratory reconstitution, researchers should use sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) depending on assay requirements. Reconstitute by gently directing liquid down the inner glass wall of the vial, allowing the cake to dissolve naturally without violent vortexing. Reconstituted aliquots should be stored at 2°C to 8°C for short-term use (under 7 days) or sub-aliquoted and frozen at -80°C to prevent degradation through repeated freeze-thaw cycles.
For academic institutions, contract research organizations (CROs), and biotechnology firms running multi-phase preclinical trials, maintaining a consistent batch supplier is critical. Fluctuations in peptide sequence purity between experimental runs can introduce unwanted confounding variables in gene expression and cytokine quantification assays.
PX1 Research maintains robust inventory controls with domestic shipping directly from facilities in California and Arizona. Same-day dispatch for orders placed Monday through Friday ensures rapid deployment to your laboratory. Institutions seeking bulk quantities or custom lot reservations can set up specialized procurement workflows through our wholesale lab account portal.
What is the primary sequence of Chonluten?
Chonluten is a synthetic tripeptide composed of L-glutamic acid, L-aspartic acid, and glycine, abbreviated as Glu-Asp-Gly.
What preclinical models are used to study Chonluten's anti-inflammatory properties?
Chonluten is primarily evaluated using primary bronchial epithelial cell cultures, alveolar macrophage cell lines, and rodent models of endotoxin-induced acute lung injury or chronic bronchial inflammation.
Why does the price of research-grade Chonluten vary across suppliers?
Price variances reflect manufacturing origin (US vs. non-regulated overseas), purity verification (>98% RP-HPLC), mass spectrometry validation, endotoxin testing, and whether lot-specific COAs are provided.
Is Chonluten approved for therapeutic or human medical use?
No. Chonluten is strictly supplied as a research compound for in vitro laboratory assays and preclinical animal research. It is not for human or veterinary use, therapy, or diagnosis.
How should lyophilized Chonluten be stored in the lab?
Lyophilized Chonluten should be stored at -20°C in a dry, dark place. Once reconstituted, solution aliquots should be kept at 2°C to 8°C for immediate use or -80°C for long-term storage.
What analytical documents accompany PX1 Research Chonluten orders?
Every lot includes a lot-specific Certificate of Analysis (COA) detailing RP-HPLC purity percentage, mass spectrometry identity verification, and LAL endotoxin assay results.
What solvents are recommended for reconstituting Chonluten for in vitro assays?
Sterile bacteriostatic water or cell-culture grade phosphate-buffered saline (PBS, pH 7.4) are standard solvents for laboratory reconstitution.
How does PX1 Research ship Chonluten orders?
Orders ship same-day (Monday through Friday) directly from dispatch centers located in California and Arizona to minimize transit time.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.